2011•Clinical RheumatologyRequires access

Effect of mycophenolate sodium in scleroderma-related interstitial lung disease

Carmen Pilar Simeón‐Aznar, Vicent Fonollosa‐Pla, Carles Tolosa-Vilella, Albert Selva-O’Callaghan, Roser Solans‐Laqué, Miquel Vilardell‐Tarrés

Open publisher page 72 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 72 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Medicine, DLCO, Vital capacity, Interstitial lung disease, Pulmonary function testing, Internal medicine, Diffusing capacity, Restrictive lung disease

Back to paper search Browse research topics Original source

Effect of mycophenolate sodium in scleroderma-related interstitial lung disease — Research Paper | ScholarLens